Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
Provided By GlobeNewswire
Last update: Oct 14, 2025
Appoints Shawn Matthews, CEO of DNA Holdings Venture, Inc., and Former CEO of Cantor Fitzgerald, to its Board of Directors
Names Thomas McLaughlin and Sara Turken, JD, as Chief Investment Officer and General Counsel, respectively
Read more at globenewswire.comNASDAQ:POAI (10/17/2025, 8:00:01 PM)
9.535
-1.46 (-13.32%)
Find more stocks in the Stock Screener
POAI Latest News and Analysis
